Warwick Investment Management Inc. Takes Position in Ventas, Inc. $VTR

by · The Cerbat Gem

Warwick Investment Management Inc. bought a new position in Ventas, Inc. (NYSE:VTR – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 9,164 shares of the real estate investment trust’s stock, valued at approximately $641,000.

Other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in Ventas in the 2nd quarter worth $344,740,000. Vanguard Group Inc. lifted its position in shares of Ventas by 4.1% in the second quarter. Vanguard Group Inc. now owns 71,796,312 shares of the real estate investment trust’s stock worth $4,533,937,000 after buying an additional 2,854,751 shares in the last quarter. Citigroup Inc. boosted its stake in Ventas by 451.9% during the second quarter. Citigroup Inc. now owns 2,316,344 shares of the real estate investment trust’s stock valued at $146,277,000 after buying an additional 1,896,627 shares during the last quarter. State Street Corp boosted its stake in Ventas by 5.2% during the second quarter. State Street Corp now owns 27,998,629 shares of the real estate investment trust’s stock valued at $1,781,267,000 after buying an additional 1,388,678 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in Ventas by 36.1% during the 2nd quarter. Invesco Ltd. now owns 4,812,970 shares of the real estate investment trust’s stock valued at $303,939,000 after buying an additional 1,275,446 shares in the last quarter. 94.18% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Ventas news, CFO Robert F. Probst sold 29,930 shares of the business’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the sale, the chief financial officer directly owned 138,434 shares of the company’s stock, valued at $10,694,026.50. The trade was a 17.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Debra A. Cafaro sold 10,322 shares of the company’s stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $77.26, for a total transaction of $797,477.72. Following the completion of the transaction, the chief executive officer owned 1,145,695 shares in the company, valued at $88,516,395.70. This represents a 0.89% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 713,520 shares of company stock valued at $52,788,577. 0.80% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

VTR has been the topic of several recent research reports. Jefferies Financial Group reaffirmed a “buy” rating and set a $93.00 price objective on shares of Ventas in a report on Monday, December 15th. Wells Fargo & Company upped their price target on shares of Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. The Goldman Sachs Group began coverage on shares of Ventas in a report on Friday. They issued a “buy” rating and a $94.00 target price on the stock. Finally, KeyCorp increased their price target on shares of Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Ventas presently has a consensus rating of “Moderate Buy” and a consensus price target of $80.65.

Read Our Latest Research Report on Ventas

Ventas Stock Performance

Ventas stock opened at $74.90 on Friday. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. The firm has a market capitalization of $35.18 billion, a P/E ratio of 144.05, a price-to-earnings-growth ratio of 1.85 and a beta of 0.78. Ventas, Inc. has a 1-year low of $56.97 and a 1-year high of $81.89. The company’s 50-day moving average is $78.25 and its 200 day moving average is $71.36.

Ventas (NYSE:VTR – Get Free Report) last released its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The firm had revenue of $1.49 billion for the quarter, compared to analysts’ expectations of $1.44 billion. During the same quarter in the prior year, the firm posted $0.80 earnings per share. The company’s quarterly revenue was up 20.5% on a year-over-year basis. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Research analysts forecast that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st will be given a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Wednesday, December 31st. Ventas’s dividend payout ratio (DPR) is 369.23%.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Featured Articles

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).